Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition

Research output: Contribution to journalLetterResearchpeer-review

Standard

Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition. / Rajabi, Nima; Nielsen, Alexander Lund; Olsen, Christian Adam.

In: A C S Medicinal Chemistry Letters, Vol. 11, No. 10, 2020, p. 1886-1892.

Research output: Contribution to journalLetterResearchpeer-review

Harvard

Rajabi, N, Nielsen, AL & Olsen, CA 2020, 'Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition', A C S Medicinal Chemistry Letters, vol. 11, no. 10, pp. 1886-1892. https://doi.org/10.1021/acsmedchemlett.9b00580

APA

Rajabi, N., Nielsen, A. L., & Olsen, C. A. (2020). Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition. A C S Medicinal Chemistry Letters, 11(10), 1886-1892. https://doi.org/10.1021/acsmedchemlett.9b00580

Vancouver

Rajabi N, Nielsen AL, Olsen CA. Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition. A C S Medicinal Chemistry Letters. 2020;11(10):1886-1892. https://doi.org/10.1021/acsmedchemlett.9b00580

Author

Rajabi, Nima ; Nielsen, Alexander Lund ; Olsen, Christian Adam. / Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition. In: A C S Medicinal Chemistry Letters. 2020 ; Vol. 11, No. 10. pp. 1886-1892.

Bibtex

@article{a600ec7443ec480f8eace63f641cba52,
title = "Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition",
author = "Nima Rajabi and Nielsen, {Alexander Lund} and Olsen, {Christian Adam}",
year = "2020",
doi = "10.1021/acsmedchemlett.9b00580",
language = "English",
volume = "11",
pages = "1886--1892",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "10",

}

RIS

TY - JOUR

T1 - Dethioacylation by sirtuins 1–3: Considerations for drug design using mechanism-based sirtuin inhibition

AU - Rajabi, Nima

AU - Nielsen, Alexander Lund

AU - Olsen, Christian Adam

PY - 2020

Y1 - 2020

U2 - 10.1021/acsmedchemlett.9b00580

DO - 10.1021/acsmedchemlett.9b00580

M3 - Letter

C2 - 33062169

VL - 11

SP - 1886

EP - 1892

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 10

ER -

ID: 238450255